RP# [002]

Related by string. rp# . RP# [003] . Rp# [002] . Rp# [001] . RP# [001] * * Rp# trillion [001] . Rp# trillion [002] . Rp# billion . HP rp# . HP rp# Point . HP rp# Cluster . HP rp# POS *

Related by context. Frequent words. (Click for all words.) 64 DB# [003] 61 BAY #-# 60 XL# [003] 60 Treanda 60 ASA# 59 OXi# 59 humanized monoclonal antibody 59 RG# [001] 59 PLX# 58 Phase 1b clinical 58 Satraplatin 58 AEZS 58 Everolimus 58 CA4P 58 MGCD# [001] 57 Debio 57 perifosine 57 Rituximab 57 phase IIb 57 Taxotere ® 57 metastatic renal cell carcinoma 57 daclizumab 57 Gemcitabine 57 Phase 1b 57 HGS ETR1 56 Phase IIb clinical 56 AT# [002] 56 ProLindac 56 Perifosine 56 PF # [001] 56 GRN#L 56 ridaforolimus 56 phase 2a 56 ofatumumab 55 Phase IIa trial 55 Campath 55 elesclomol 55 Phase 2a trial 55 Phase 2b clinical 55 Phase Ib 55 PEG Interferon lambda 55 FTY# 55 Phase IIa clinical 55 HE# [002] 55 Phase 2b trial 55 NGX# 55 AZD# 55 vandetanib 55 TNFerade 55 CoFactor 55 carfilzomib 55 PRX# 55 Marqibo 55 belinostat 55 CYT# 55 biologic therapy 55 Pixantrone 55 antitumor activity 54 tivozanib 54 antisense drug 54 picoplatin 54 ADVEXIN 54 Bavituximab 54 MT# [002] 54 NU# [001] 54 temsirolimus 54 CTCE 54 Vectibix 54 telbivudine 54 Sorafenib 54 ZYBRESTAT 54 IMGN# 54 CB# [002] 54 ARQ 54 Phase III clinical 54 bavituximab 54 Phase 2a 54 investigational compound 54 TroVax 54 Phase 2b 53 kinase inhibitor 53 satraplatin 53 DG# [001] 53 Ventavis 53 AP# [003] 53 Phase 2b study 53 dose escalation trial 53 VEGF Trap 53 Phase 2a clinical 53 clofarabine 53 TORISEL 53 refractory multiple myeloma 52 XMT 52 investigational oral 52 Phase IIb 52 Actemra 52 imetelstat 52 NP# [002] 52 blinatumomab 52 TRIOLEX 52 pharmacokinetic profile

Back to home page